Publication | Closed Access
A novel thermolytic annulation of an oxazolidinone: an enantiospecific synthesis of (-)-slaframine
31
Citations
0
References
1992
Year
Bioorganic ChemistryChemical AnalysisAltmetric Attention ScoreOrganic ChemistryChemistryNovel Thermolytic AnnulationPharmaceutical ChemistryBiochemistryChemometricsSocial Media PresenceEnantiospecific SynthesisPharmacologyNatural Product SynthesisEnantioselective SynthesisDonut IconNatural SciencesMedicineSynthetic ChemistryDrug Discovery
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTA novel thermolytic annulation of an oxazolidinone: an enantiospecific synthesis of (-)-slaframineMukund P. Sibi, James W. Christensen, Biqin Li, and Paul A. RenhoweCite this: J. Org. Chem. 1992, 57, 16, 4329–4330Publication Date (Print):July 1, 1992Publication History Published online1 May 2002Published inissue 1 July 1992https://pubs.acs.org/doi/10.1021/jo00042a002https://doi.org/10.1021/jo00042a002research-articleACS PublicationsRequest reuse permissionsArticle Views251Altmetric-Citations24LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-AlertscloseSupporting Info (1)»Supporting Information Supporting Information Get e-Alerts